Portola Pharmaceuticals, Inc. Common Stock, Value, Issued
Portola Pharmaceuticals, Inc. had Common Stock, Value, Issued of $80.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2020-05-11
- 2020-03-31: Common Stock, Value, Issued $80.00K.
- 2019-12-31: Common Stock, Value, Issued $80.00K.
- 2019-09-30: Common Stock, Value, Issued $79.00K.
- 2019-06-30: Common Stock, Value, Issued $70.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2020-03-31 | $80.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $80.00K 10-Q · filed 2020-05-11 |
| 2019-09-30 | $79.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $70.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $70.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $68.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $67.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $66.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $67.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $66.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | $67.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $59.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $58.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $57.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $57.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $57.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $57.00K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $57.00K 10-K · filed 2017-03-01 |
| 2015-09-30 | $53.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $52.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $52.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $49.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | $42.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $41.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $41.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $41.00K 10-K · filed 2015-03-02 |
| 2013-09-30 | $35.00K 10-Q · filed 2013-11-06 |
| 2013-06-30 | $35.00K 10-Q · filed 2013-08-14 |
| 2012-12-31 | $1.00K 10-K · filed 2014-03-03 |